Cargando…

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model

BACKGROUND: Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden of 1.2 million pediatric malaria cases and 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Kathryn D., Higgins, Colleen R., Laing, Sarah K., Mwila, Chiluba, Kobayashi, Tamaki, Ippolito, Matthew M., Sylvia, Sean, Ozawa, Sachiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350731/ https://www.ncbi.nlm.nih.gov/pubmed/32646393 http://dx.doi.org/10.1186/s12889-020-08852-w

Ejemplares similares

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
por: Ozawa, Sachiko, et al.
Publicado: (2019)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
por: Chen, Hui-Han, et al.
Publicado: (2021)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
por: Higgins, Colleen R., et al.
Publicado: (2023)

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020)

Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea
por: Kaur, Harparkash, et al.
Publicado: (2017)

A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better
por: Tabernero, Patricia, et al.
Publicado: (2015)

Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
por: Ozawa, Sachiko, et al.
Publicado: (2018)

Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems
por: Chabalenge, Billy, et al.
Publicado: (2022)

Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi
por: Khuluza, Felix, et al.
Publicado: (2017)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
por: Zabala, Guillermo A, et al.
Publicado: (2022)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
por: Cavany, Sean, et al.
Publicado: (2023)

Combatting Substandard and Falsified Medicines: A View from Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines
por: Wang, Wenbo, et al.
Publicado: (2019)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2022)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
por: Sweileh, Waleed M.
Publicado: (2021)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021)

Mobile apps for detecting falsified and substandard drugs: A systematic review
por: Ciapponi, Agustín, et al.
Publicado: (2021)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
por: Wada, Yusuf Hassan, et al.
Publicado: (2022)

Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies
por: Antignac, Marie, et al.
Publicado: (2019)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
por: Akpobolokemi, Tamara, et al.
Publicado: (2022)

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
por: Yakhkind, Aleksandra, et al.
Publicado: (2022)

Poor-quality antimalarials further health inequities in Uganda
por: Evans, Daniel R, et al.
Publicado: (2019)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

Retracted and Republished: A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2019)

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
por: Hauk, Cathrin, et al.
Publicado: (2021)

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
por: Ahmed, Jamee, et al.
Publicado: (2022)

Triboelectric nanogenerator (TENG) mass spectrometry of falsified antimalarials
por: Bernier, Matthew C., et al.
Publicado: (2018)

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018)

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
por: Macé, Cécile, et al.
Publicado: (2023)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy
por: Lawson, Graham, et al.
Publicado: (2018)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab
por: Petersen, Albert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1l7kumr0vvg2oqpi8ti7ifum54